Embed Notice

HTML Code

<blockquote style="position: relative; padding-left: 55px;"><section><a href="https://mstdn.social/users/erictopol/statuses/112617141745324997">Eric Topol (erictopol@mstdn.social)'s status on Saturday, 15-Jun-2024 08:44:01 JST</a><a href="https://mstdn.social/@erictopol" title="erictopol@mstdn.social"><img src="https://gnusocial.jp/avatar/28946-48-20221117011128.webp" width="48" height="48" alt="Eric Topol" style="position: absolute; left: 0; top: 0;">Eric Topol</a></section><article><p>Very good news on the fall booster. The FDA changed course from JN.1 to select KP.2, which in the animal model has a &gt;3-fold induction of neutralizing antibodies vs KP.3, the SARS-CoV2 variant that is on its way to dominance in the US (and causing trouble in multiple countries)<br><a href="https://www.nbcnews.com/health/health-news/fda-recommends-covid-vaccine-update-target-kp2-strain-rcna157089" rel="nofollow noreferrer">https://www.nbcnews.com/health/health-news/fda-recommends-covid-vaccine-update-target-kp2-strain-rcna157089</a></p></article><footer><a rel="bookmark" href="https://gnusocial.jp/conversation/3243820#notice-6401795">In conversation</a><time datetime="2024-06-15T08:44:01+09:00" title="Saturday, 15-Jun-2024 08:44:01 JST">about a year ago</time> <span>from <span><a href="https://mstdn.social/@erictopol/112617141745324997" rel="external" title="Sent from mstdn.social via ActivityPub">mstdn.social</a></span></span><a href="https://mstdn.social/@erictopol/112617141745324997">permalink</a><h4>Attachments</h4><ol><li><article><header><div>Domain not in remote thumbnail source whitelist: media-cldnry.s-nbcnews.com</div><h5><a href="https://www.nbcnews.com/health/health-news/fda-recommends-covid-vaccine-update-target-kp2-strain-rcna157089">FDA advises Covid vaccine makers to target KP.2 for fall shots</a></h5><div> from <span>NBCNews</span></div></header><div>The selection comes as Covid cases are rising in some parts of the country.</div><footer></footer></article></li></ol></footer></blockquote>

Corresponding Notice

Embed this notice
Eric Topol (erictopol@mstdn.social)'s status on Saturday, 15-Jun-2024 08:44:01 JST Eric Topol
Very good news on the fall booster. The FDA changed course from JN.1 to select KP.2, which in the animal model has a >3-fold induction of neutralizing antibodies vs KP.3, the SARS-CoV2 variant that is on its way to dominance in the US (and causing trouble in multiple countries)
https://www.nbcnews.com/health/health-news/fda-recommends-covid-vaccine-update-target-kp2-strain-rcna157089
In conversationabout a year ago from mstdn.socialpermalink
Attachments
1. Domain not in remote thumbnail source whitelist: media-cldnry.s-nbcnews.com
  FDA advises Covid vaccine makers to target KP.2 for fall shots
  from NBCNews
  The selection comes as Covid cases are rising in some parts of the country.

Public

Embed Notice

HTML Code

Corresponding Notice